PROCEPT BioRobotics Timeline

Events

• 2024-08-20 - Regulatory - PROCEPT BioRobotics receives FDA clearance for HYDROS robotic system - PROCEPT BioRobotics received FDA 510(k) clearance for HYDROS, its next-generation robotic system for Aquablation therapy. HYDROS extends the company''s urology robotics platform with image-guided planning and treatment workflow updates. The regulatory… - source: ir.procept-biorobotics.com
• 2021-09-15 - Market Signal - PROCEPT BioRobotics prices Nasdaq IPO - PROCEPT expected its common stock to begin trading on the Nasdaq Global Market on September 15, 2021. The IPO was priced at $25.00 per share. The company offered all shares in the upsized offering. - source: ir.procept-biorobotics.com
• 2018-02-21 - Funding - PROCEPT BioRobotics raises $118 million equity financing - Equity financing: USD 118,000,000. Viking Global Investors led or co-led the financing. PROCEPT BioRobotics raised $118 million in equity financing to support worldwide commercialisation of Aquablation therapy and the AquaBeam surgical robotics system. - source: ir.procept-biorobotics.com